Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lucien Gazi
The Effect of Food on the Bioavailability of Panobinostat, an Orally Active Pan-Histone Deacetylase Inhibitor, in Patients With Advanced Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor
PLoS ONE
Multidisciplinary
Related publications
Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
PLoS ONE
Multidisciplinary
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Effect of Histone Deacetylase Inhibitor on Epithelial-Mesenchymal Transition of Liver Fibrosis
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Antioxidants and Redox Signaling
Cell Biology
Molecular Biology
Biochemistry
Clinical Biochemistry
Medicine
Physiology
Antitumor Effect of Liposomal Histone Deacetylase Inhibitor-Lipid Conjugates in Vitro
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer With Low Xist Expression
Clinical Cancer Research
Cancer Research
Oncology
Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
Pharmacotherapy
Pharmacology
Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology